1. How the tortoises in the COVID vaccine race could still win out — Moderna's COVID vaccine investigator leaves FDA ad comm over conflict of interest — Decentralized clinical trials won't slow down after pandemic ends — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Novartis could settle for $1B as part of federal kickback lawsuit: report

Discussion in 'Whistleblower News' started by cafead, May 16, 2019 at 12:23 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Nov 21, 2001
    Likes Received:
    Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $10,000 dinners and fishing trips for doctors, signs pointed to the Swiss drugmaker finally having its day in court. Now it looks like that may not happen.

    Novartis could be approaching a billion-dollar settlement with the U.S. government as part of a whistleblower lawsuit accusing the company of bribing doctors to boost subscriptions of its drugs, sources told STAT.